Company intelligence / Profile preview

Lightmed OptiMed

San Clemente, California, United States

Ownership: Private
Employees: ~109
Development stage: Other

Overview

Lightmed's laser and diagnostic systems, including LIGHTLas SLT Deux and TruScan with SP-Mode®, are clinically proven for safe and effective reduction of intraocular pressure in glaucoma and for stabilization of retinal thickness in diabetic macular edema, with broad usage in commercial clinical practice and numerous peer-reviewed clinical studies supporting their efficacy and safety.[9]

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

OptiMed (distribution partner in New Zealand and Australia)

Beyond the preview

Go deeper on Lightmed OptiMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lightmed OptiMed.

Explore the full profile